EPIGEFF

Main information

  • Trade name:
  • EPIGEFF 30 TAB
  • Dosage:
  • 250MG
  • Pharmaceutical form:
  • TAB
  • Composition:
  • 30
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EPIGEFF 30 TAB
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

27-7-2018

Pending EC decision:  Gefitinib Mylan, gefitinib, Opinion date: 26-Jul-2018

Pending EC decision: Gefitinib Mylan, gefitinib, Opinion date: 26-Jul-2018

Europe - EMA - European Medicines Agency

1-10-2018

Gefitinib Mylan (Mylan S.A.S.)

Gefitinib Mylan (Mylan S.A.S.)

Gefitinib Mylan (Active substance: gefitinib) - Centralised - Authorisation - Commission Decision (2018)6406 of Mon, 01 Oct 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4826

Europe -DG Health and Food Safety